Retinal hemorrhages as a manifestation of hemorrhagic syndrome in patients with acute leukemia

Background. Thrombosis or hemorrhage syndrome is often the first symptom of acute leukemia. Despite modern treatments and blood replacement therapy, many patients die from hemorrhagic syndrome. According to literature data, retinal hemorrhages in patients with acute leukemia are observed in 9–90 % of cases and can be an early manifestation of the disease. Aim. To analyze retinal hemorrhages as a manifestation of hemorrhagic syndrome. Materials and methods. The study included 93 patients (186 eyes) with confirmed acute leukemia aged 18–79 years. In 30 of 93 patients, cutaneous hemorrhagic syndrome was diagnosed, in 8 patients, skin hemorrhages involved mucous membranes. Results. All patients were divided into two groups: 60 patients with signs of hemorrhagic syndrome including hemorrhages in the ocular fundus (mean platelet count 64.4 × 109/L; median 40 × 109/L) and 34 patients without signs of hemorrhagic syndrome (mean platelet count 129 × 109/L; median 100.5 × 109/L). One patient was randomized into 2 groups. Additionally, all patients were divided into 4 groups: 26 patients with confirmed hemorrhagic syndrome, including those with hemorrhages in the ocular fundus (mean platelet count 97.3 × 109/L (min–max 2.98–129 × 109/L; median 21 × 109/L)); 22 patients with retinal hemorrhages but without generalized hemorrhagic syndrome (mean platelet count 148.7 × 109/L (min–max 1–245 × 109/L; median 107 × 109/L)), of whom 6 patients were diagnosed with neuroleukaemia; 13 patients with hemorrhagic syndrome but without changes in the ocular fundus (mean platelet count 127.5 × 109/L (min–max 16–138 × 109/L; median 40 × 109/L)); 34 patients without hemorrhagic syndrome, including no signs in the ocular fundus (mean platelet count 129 × 109/L (min–max 10–324 × 109/L; median 100.5 × 109/L)). Two of the 93 patients were included in two groups simultaneously. Conclusion. In patients from the group with hemorrhages in the ocular fundus but no other manifestations of hemorrhagic syndrome (n = 22), the platelet count was 148.7 × 109/L (min–max 1–245 × 109/L; median 107 × 109/L), which was the highest value compared to the other groups. This underscores the necessity of a mandatory ophthalmological examination for all patients diagnosed with acute leukemia.

Authors

Institutions

Publication Details

Journal
MD-Onco
Published
2026-11-17
DOI
https://doi.org/10.17650/2782-3202-2026-6-3-62-66
Primary Topic
Retinal and Optic Conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Retinal hemorrhages as a manifestation of hemorrhagic syndrome in patients with acute leukemia

Е. Е. Гришина, Tatiana A. Mitina, P. I. Semenikhina
MD-Onco
Retinal and Optic Conditions
article

Retinal hemorrhages as a manifestation of hemorrhagic syndrome in patients with acute leukemia

Е. Е. Гришина, Tatiana A. Mitina, P. I. Semenikhina
article en

Abstract

Background. Thrombosis or hemorrhage syndrome is often the first symptom of acute leukemia. Despite modern treatments and blood replacement therapy, many patients die from hemorrhagic syndrome. According to literature data, retinal hemorrhages in patients with acute leukemia are observed in 9–90 % of cases and can be an early manifestation of the disease. Aim. To analyze retinal hemorrhages as a manifestation of hemorrhagic syndrome. Materials and methods. The study included 93 patients (186 eyes) with confirmed acute leukemia aged 18–79 years. In 30 of 93 patients, cutaneous hemorrhagic syndrome was diagnosed, in 8 patients, skin hemorrhages involved mucous membranes. Results. All patients were divided into two groups: 60 patients with signs of hemorrhagic syndrome including hemorrhages in the ocular fundus (mean platelet count 64.4 × 109/L; median 40 × 109/L) and 34 patients without signs of hemorrhagic syndrome (mean platelet count 129 × 109/L; median 100.5 × 109/L). One patient was randomized into 2 groups. Additionally, all patients were divided into 4 groups: 26 patients with confirmed hemorrhagic syndrome, including those with hemorrhages in the ocular fundus (mean platelet count 97.3 × 109/L (min–max 2.98–129 × 109/L; median 21 × 109/L)); 22 patients with retinal hemorrhages but without generalized hemorrhagic syndrome (mean platelet count 148.7 × 109/L (min–max 1–245 × 109/L; median 107 × 109/L)), of whom 6 patients were diagnosed with neuroleukaemia; 13 patients with hemorrhagic syndrome but without changes in the ocular fundus (mean platelet count 127.5 × 109/L (min–max 16–138 × 109/L; median 40 × 109/L)); 34 patients without hemorrhagic syndrome, including no signs in the ocular fundus (mean platelet count 129 × 109/L (min–max 10–324 × 109/L; median 100.5 × 109/L)). Two of the 93 patients were included in two groups simultaneously. Conclusion. In patients from the group with hemorrhages in the ocular fundus but no other manifestations of hemorrhagic syndrome (n = 22), the platelet count was 148.7 × 109/L (min–max 1–245 × 109/L; median 107 × 109/L), which was the highest value compared to the other groups. This underscores the necessity of a mandatory ophthalmological examination for all patients diagnosed with acute leukemia.

MD-OncoVol. 6(3)
Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky (RU)
Retinal and Optic Conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon